Price T Rowe Associates Inc Abbott Laboratories Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,137,172 shares of ABT stock, worth $430 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,137,172

Previous 4,292,863 3.63%

Holding current value

$430 Million

Previous $473 Million 0.48%

% of portfolio

0.06%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $17.1 Million - $18.8 Million	-155,691 Reduced 3.63%	4,137,172 $470 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $4,419 - $5,409	-49 Reduced -0.0%	4,292,863 $473 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $3.06 Million - $3.67 Million	-32,026 Reduced 0.74%	4,292,912 $416 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $22.1 Million - $24.6 Million	219,349 Added 5.34%	4,324,938 $472 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $16.5 Million - $19.5 Million	-170,712 Reduced 3.99%	4,105,589 $416 Million

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $566 Million - $664 Million	-5,950,387 Reduced 58.18%	4,276,301 $469 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $78.8 Million - $91.2 Million	813,894 Added 8.65%	10,226,688 $990 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $110 Million - $133 Million	1,074,432 Added 12.89%	9,412,794 $1.02 Billion
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $304 Million - $370 Million	2,663,477 Added 46.93%	8,338,362 $987 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $95.1 Million - $116 Million	-823,241 Reduced 12.67%	5,674,885 $799 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $257 Million - $284 Million	-2,199,778 Reduced 25.29%	6,498,126 $768 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $180 Million - $212 Million	-1,703,604 Reduced 16.38%	8,697,904 $1.01 Billion
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $698 Million - $822 Million	6,413,312 Added 160.81%	10,401,508 $1.25 Billion
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $419 Million - $456 Million	3,988,196 New	3,988,196 $437 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Abbott Laboratories Transaction History